Request Demo
Last update 26 Feb 2026
AG-01(A&G Pharmaceutical Inc.)
Last update 26 Feb 2026
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism PGRN inhibitors(Progranulin inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with AG-01(A&G Pharmaceutical Inc.)NCT05627960
FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma
100 Clinical Results associated with AG-01(A&G Pharmaceutical Inc.)
Login to view more data
100 Translational Medicine associated with AG-01(A&G Pharmaceutical Inc.)
Login to view more data
100 Patents (Medical) associated with AG-01(A&G Pharmaceutical Inc.)
Login to view more data
100 Deals associated with AG-01(A&G Pharmaceutical Inc.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 14 Feb 2022 | |
| Advanced Triple-Negative Breast Carcinoma | Phase 1 | United States | 14 Feb 2022 | |
| Hormone refractory breast cancer | Phase 1 | United States | 14 Feb 2022 | |
| Mesothelioma | Phase 1 | United States | 14 Feb 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | 14 Feb 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free